ARCHIVES

Response From Center Representatives In L.A. To NCI Questions Is “Frusterating,” DeVita Says

This article is from The Cancer Letter archive.

Vol. 10 No. 15 | April 13, 1984

Download PDF Visit The Full Archive

Related Articles

Herceptin Lowers Recurrence In Early Breast Cancer

November 25, 2005

NCI to Undergo More GAO Probes

July 15, 1977

Pacific Yew Act Would Result In Duplications, Delays In Taxol Production, Witnesses Say

March 13, 1992

Healy Sworn In, Calls For ‘Operation Bethesda Storm’

July 12, 1991

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

A Conversation with MSKCC’s José Baselga: We Need to Increase Our Reach

September 27, 2013